Anna Legassie is the head of strategy and development for a health economics and policy research center driving a research agenda that elevates patient engagement in value assessment in healthcare – ensuring that the barriers to treatments that she’s experienced are addressed on a system level.

Diagnosed with systemic juvenile idiopathic arthritis (SJIA) at age 11, Anna uses her expertise as a patient to consult with healthcare start-ups, pharmaceutical companies, and other healthcare organizations collaborating to incorporate the patient voice into healthcare design, technology, and policy reform. Currently she is on the Massachusetts Leadership Board of the Arthritis Foundation and also serves on the Foundation’s National Advocacy Committee. She is a member of the Tufts Medical Center Patient and Family Advisory Council (PFAC) and is on the patient advisory board of Clara Health.